INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY

Master's

Saved in:
Bibliographic Details
Main Author: RAVURU SUBRAMANYAM MOHAN
Other Authors: SURGERY
Format: Theses and Dissertations
Published: 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/177083
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-177083
record_format dspace
spelling sg-nus-scholar.10635-1770832024-10-26T19:43:49Z INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY RAVURU SUBRAMANYAM MOHAN SURGERY Bladder cancer Low-dose BCG Interferon alpha-2b Safety Efficacy Drug Toxicity Cytokines Master's MASTER OF SCIENCE 2020-10-05T04:57:20Z 2020-10-05T04:57:20Z 1999 Thesis RAVURU SUBRAMANYAM MOHAN (1999). INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY. ScholarBank@NUS Repository. https://scholarbank.nus.edu.sg/handle/10635/177083 CCK BATCHLOAD 20201023
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Bladder cancer
Low-dose BCG
Interferon alpha-2b
Safety
Efficacy
Drug
Toxicity
Cytokines
spellingShingle Bladder cancer
Low-dose BCG
Interferon alpha-2b
Safety
Efficacy
Drug
Toxicity
Cytokines
RAVURU SUBRAMANYAM MOHAN
INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY
description Master's
author2 SURGERY
author_facet SURGERY
RAVURU SUBRAMANYAM MOHAN
format Theses and Dissertations
author RAVURU SUBRAMANYAM MOHAN
author_sort RAVURU SUBRAMANYAM MOHAN
title INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY
title_short INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY
title_full INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY
title_fullStr INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY
title_full_unstemmed INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY
title_sort intravesical bacillus calmette-guerin (bcg) and interferon alpha-2b in the treatment of superficial bladder cancer - a clinical and immunological study
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/177083
_version_ 1821191629771374592